Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Trends in Colon Cancer

      January 5, 2015
      By Lisa Schulmeister, MN, RN, ACNS-BC, OCN , FAAN
      Article

      Decline seen for older adults but rates are rising for young adults.

      Researchers from the University of Texas M.D. Anderson Cancer Center in Houston conducted a large retrospective cohort study of colon cancer using the Surveillance, Epidemiology, and End Results registry. Age at diagnosis was analyzed in 15-year intervals starting at the age of 20. Data included all 393,241 patients diagnosed with colon or rectal cancer (CRC) from January 1, 1975 through December 31, 2010.

      The overall age-adjusted CRC incidence rate decreased by 0.92% between 1975 and 2010, and there was a steady decline in the incidence of CRC in people age 50 years or older; however, the opposite trend was observed for young adults. For patients aged 20 to 34, the incidence rates of localized, regional, and distant colon and rectal cancers have increased. If the current trends continue, there will be rise in colon cancer incidence among young adults by 2030. The incidence is expected to increase by 90% for individuals who are age 20 to 124% for those who are 34 years old. The researchers concluded that further studies are needed to determine the cause for these trends and identify potential preventive and early detection strategies. They noted that behavioral factors, such as obesity and physical inactivity, may play a role in the increasing incidence of CRC among young people, and the typical modern diet high in red meat and processed foods also may play a role in the rising incidence.

      Reference

      Bailey CE et al. Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010. JAMA Surg. Published online 11/5/14, doi:10.1001/jamasurg.2014.1756.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a man wearing a suit with a bowtie in front of an Oncology Nursing News backdrop
      Image of a nurse handing a patient pills
      Photo of an open bottle of pills
      Related Content

      Photo of a syringe and a vaccine bottle

      Amphiphile Vaccine Extends RFS in KRAS+ Pancreatic Cancer

      Jonah Feldman
      September 16th 2025
      Article

      The Vitals

      ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

      Lindsay Fischer
      September 16th 2025
      Podcast

      Graphic of a person's gastrointestinal tract.

      Retifanlimab Lengthens Survival for Patients With Anal Cancer

      Sabrina Serani
      September 16th 2025
      Article

      The Vitals

      Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

      Lindsay Fischer
      September 16th 2025
      Podcast

      Graphic of a person's esophagus and stomach

      Zanidatamab/Chemo Yields Durable Response in HER2+ Gastroesophageal Cancer

      Russ Conroy
      September 16th 2025
      Article

      Anatomical image of a pancreas with tumors

      Atebimetinib Combo Shows Survival Signal in First-Line Pancreatic Cancer

      Chris Ryan
      September 16th 2025
      Article
      Related Content

      Photo of a syringe and a vaccine bottle

      Amphiphile Vaccine Extends RFS in KRAS+ Pancreatic Cancer

      Jonah Feldman
      September 16th 2025
      Article

      The Vitals

      ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

      Lindsay Fischer
      September 16th 2025
      Podcast

      Graphic of a person's gastrointestinal tract.

      Retifanlimab Lengthens Survival for Patients With Anal Cancer

      Sabrina Serani
      September 16th 2025
      Article

      The Vitals

      Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

      Lindsay Fischer
      September 16th 2025
      Podcast

      Graphic of a person's esophagus and stomach

      Zanidatamab/Chemo Yields Durable Response in HER2+ Gastroesophageal Cancer

      Russ Conroy
      September 16th 2025
      Article

      Anatomical image of a pancreas with tumors

      Atebimetinib Combo Shows Survival Signal in First-Line Pancreatic Cancer

      Chris Ryan
      September 16th 2025
      Article

      Latest Conference Coverage

      Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care

      Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC

      Lutetium Lu 177 Dotatate Brings Partial Response in Metastatic BP-NETs

      Safety Management With Amivantamab Plus Lazertinib in NSCLC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      259 Prospect Plains Rd, Bldg H,
      Monroe, NJ 08831

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.